Navigation Links
Alexza Stockholders Approve Share Issuance to Symphony Capital and Alexza Completes Acquisition of Symphony Allegro
Date:8/26/2009

MOUNTAIN VIEW, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that during a special meeting of stockholders held today, its stockholders approved the proposal to issue shares of the Company's common stock and warrants to purchase shares of the Company's common stock to Symphony Capital Partners, LP and their co-investors. Subsequent to this vote, Alexza completed its acquisition of Symphony Allegro, and as a result, Alexza reacquired all rights to AZ-004, AZ-104 and AZ-002.

"We are pleased that our stockholders have overwhelmingly supported this transaction," said Thomas B. King, Alexza President and CEO. "We have reacquired full ownership of the three product candidates being developed in the Symphony Allegro partnership, and we welcome Symphony Capital Partners and their co-investors as new Alexza stockholders."

The successful stockholder vote was a condition to the completion of Alexza's previously announced option exercise to purchase all of the equity of Symphony Allegro. In June 2009, Alexza and Symphony Capital Partners announced that they had negotiated new terms to satisfy the exercise price for Alexza's option exercise to acquire Symphony Allegro. Under the terms of the Amended and Restated Purchase Option Agreement, Alexza:

  • issued 10 million shares of Alexza common stock to Symphony Capital and its co-investors,
  • issued five-year warrants for 5 million shares of Alexza common stock to Symphony Capital and its co-investors, at an exercise price of $2.26 per share (a 25% premium to the 30-day trading average closing price of the Company's common stock prior to the June announcement of the option exercise),
  • canceled previously outstanding five-year war
    '/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Alexza to Announce 2009 First Quarter Financial Results and Update Its Clinical Pipeline Status on Thursday, May 7, 2009
2. Alexzas Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference
3. Alexzas Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
4. Alexza Consolidates Operations to Focus Resources on AZ-004 (Staccato(R) Loxapine) for Acute Agitation
5. Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation
6. Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday, August 6, 2008
7. Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
8. Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
9. Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
10. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
11. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Al Khaimah, United Arab Emirates (UAE) (PRWEB) July 23, ... firm Grace Century recently announced that its ... Dr. Jim Vaught , Ph.D. to its growing Advisory ... said, “We are very pleased to have Dr. Vaught ... with the scientific depth and expertise that Provia’s management ...
(Date:7/23/2014)... Physicists Sergei Filippov (MIPT and Russian Quantum Center ... Brno, Czech Republic, and the Institute of Physics ... preserve quantum entanglement of particles passing through an ... long distances. Details are provided in an article ... (see preprint). , Quantum entangled particles are ...
(Date:7/23/2014)... 2014  AuraSense Therapeutics, the pioneer in developing spherical ... and immunotherapeutic agents, announced today that ... executive leadership team as chief financial officer ... joining AuraSense Therapeutics, Mr. Snyder was Executive ... Cellular Dynamics International Inc., where he was ...
(Date:7/23/2014)... July 23, 2014  Having the right people at ... to accelerating business growth and achieving clinical and operational ... (AHA) Leadership Summit, July 20-22, 2014, in ... hospital executives and healthcare experts discussing how partnerships have ... , President & Chief Executive Officer of Cape Regional ...
Breaking Biology Technology:Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2
... At least 170 potentially fraudulent Web sites soliciting ... have turned up in a search conducted by ... MasterCard International. , ,The two companies paired up ... the activity of Web sites and e-mail distributions created ...
... The National Institute of Information and Communications ... with the University of Wisconsin-Madison to develop new educational ... that UW-Madison made available to developers in October. , ... interaction and resource sharing among large numbers of users. ...
... Got Game (2004, Harvard Business School Press) takes a ... who grew up playing them. , ,Authors John C. ... and surveys to give business managers a lesson on how ... whose ways of thinking on competitiveness, risk-taking and everything ...
Cached Biology Technology:NameProtect roots out fake tsunami-related donation sites 2Got Game makes big claims; can 90 million people think the same? 2
(Date:7/24/2014)... is available in German . ... Norway and they are a common sight on the roads ... cars topped the list of new vehicle registrations for the ... in Germany, where electric vehicles claim only a small portion ... roads in Germany, only a mere 8000 are electric powered. ...
(Date:7/24/2014)... are, theres a virus living inside your gut that ... study led by researchers at San Diego State University ... is host to a newly described virus, named crAssphage, ... gut bacteria, Bacteroidetes . This phylum of bacteria ... other gut-related diseases. The research appears today in ...
(Date:7/23/2014)... Agency (EPA) today announced that environmental health scientist ... School of Public Health and Health Sciences (SPHHS) ... Results (STAR) grant to measure indoor air quality ... subarctic North America to determine possible health effects ... recommendations for mitigation. , Peltier, who will lead ...
Breaking Biology News(10 mins):Nano-supercapacitors for electric cars 2Nano-supercapacitors for electric cars 3Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3Studying impacts of indoor air pollution on tribal communities 2Studying impacts of indoor air pollution on tribal communities 3
... suggests that just one or two individual herpes virus particles attack ... in a bottleneck in which the infection may be vulnerable to ... cells by bombarding them with millions of particles, herpes simplex virus ... genital lesions requires just one or two viral particles to ...
... older Americans shows those who have limited mobility and low ... times more likely to report that they often don,t have ... who were not frail. The nationally representative study of ... United States uses data from the Third National Health and ...
... The patients have single short fingers (metacarpals) and toes ... a shortened skeleton. This hereditary disease is called brachydactyly ... Dr. Philipp G. Maass from the research group of ... Research Center (ECRC), a joint cooperation between the Charit ...
Cached Biology News:Princeton researchers identify unexpected bottleneck in the spread of herpes simplex virus 2Princeton researchers identify unexpected bottleneck in the spread of herpes simplex virus 3Older adults who are frail much more likely to be food insufficient, according to national study 2New findings on gene regulation and bone development 2New findings on gene regulation and bone development 3New findings on gene regulation and bone development 4
... polyclonal to ThPok ( Abpromise for all ... peptide conjugated to KLH derived from within residues ... (Note: the amino acid sequence is proprietary) ... Entrez Gene ID: 51043 ...
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
Pronase Reagent...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Biology Products: